Fundz

Shift Bioscience raised $16M in a seed funding round led by Business Growth Fund to develop its AI cell simulation platform aimed at reversing age-related illnesses.

PRIVATEOct 15, 2024

Amount Raised

$16 Million

Round Type

Seed

CambridgeBiotechnologyHealth CareArtificial IntelligenceTherapeuticsMachine Learning

Investors

Jonathan MilnerKindred CapitalF Prime CapitalBusiness Growth Fund

Description

Shift Bioscience, a Cambridge-based startup, has announced the closure of a $16 million seed funding round. The funding, led by the Business Growth Fund, will support the development of their innovative AI cell simulation platform designed to combat age-related illnesses through cellular reprogramming.

Who to call at Shift Bioscience, and when

A new round usually means Shift Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Shift Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Shift Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Shift Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Shift Bioscience

Location

Cambridge, England, United Kingdom

About

Shift Bioscience is a Cambridge-based startup founded in 2017 that is exploring how generative AI models can be utilized to reverse the ageing process by rejuvenating cells. The company aims to address age-related illnesses through cellular reprogramming and has developed an AI cell simulation platform. Their technology seeks to predict gene sets that safely rejuvenate specific cells, tackling conditions like cardiovascular disease and osteoarthritis. Shift Bioscience represents an innovative approach in the biotech sector focused on cell simulation for target discovery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Shift Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Shift Bioscience's next move

See what Strategic adds

Shift Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.